Skip to main navigation Skip to search Skip to main content

Serum levels of insulin-like growth factor I, II, and binding protein 3, transforming growth factor β-1, soluble Fas ligand and superoxide dismutase activity in stomach cancer cases and their controls in the JACC study

  • Hiroshi Yatsuya
  • , Hideaki Toyoshima
  • , Koji Tamakoshi
  • , Akiko Tamakoshi
  • , Takaaki Kondo
  • , Norihiko Hayakawa
  • , Kiyomi Sakata
  • , Shogo Kikuchi
  • , Yoshiharu Hoshiyama
  • , Yoshihisa Fujino
  • , Tetsuya Mizoue
  • , Noritaka Tokui
  • , Takesumi Yoshimura
  • , Mitsuru Mori
  • , Yutaka Motohashi
  • , Ichiro Tsuji
  • , Yosikazu Nakamura
  • , Hiroyasu Iso
  • , Haruo Mikami
  • , Yutaka Inaba
  • Hiroshi Suzuki, Hiroyuki Shimizu, Kenji Wakai, Shinkan Tokudome, Yoshinori Ito, Shuji Hashimoto, Akio Koizumi, Takashi Kawamura, Yoshiyuki Watanabe, Tsuneharu Miki, Chigusa Date, Takayuki Nose, Akira Shibata, Naoyuki Okamoto, Hideo Shio, Yoshiyuki Ohno, Tomoyuki Kitagawa, Toshio Kuroki, Kazuo Tajima

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Serum levels of insulin-like growth factor I, II, and binding protein 3, transforming growth factor β-1, soluble Fas ligand and superoxide dismutase activity in stomach cancer cases and their controls in the JACC study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Keyphrases